YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Investors were disappointed with Pro Medicus Limited's (ASX:PME) recent earnings release. Our analysis found several concerning factors in the earnings report beyond the strong statutory profit number. This technology could replace compute…
What are the early trends we should look for to identify a stock that could multiply in value over the long term? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of…
As Australian shares continue their upward trajectory, buoyed by a rally in the S&P 500 and anticipation surrounding upcoming inflation data, investors are closely watching how these factors might influence future Reserve Bank of Australia…
Pro Medicus Limited (ASX:PME) shareholders might be concerned after seeing the share price drop 29% in the last quarter. But over five years returns have been remarkably great. To be precise, the stock price is 401% higher than it was five…
Key Insights Pro Medicus' significant insider ownership suggests inherent interests in company's expansion 52% of the business is held by the top 4 shareholders Insiders have been buying lately Trump has pledged to "unleash" American oil a…
As the Australian market navigates a mixed landscape with tech stocks showing resilience amidst broader sector fluctuations, investors are keenly observing how economic indicators and global events influence small-cap performance. In this…
Over the last year, a good number of insiders have significantly increased their holdings in Pro Medicus Limited (ASX:PME). This is encouraging because it indicates that insiders are more optimistic about the company's prospects. Although…
Visage introduces Visage 7 | Digital Pathology and AI innovations SAN DIEGO, Nov. 19, 2025 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will showcase a series o…
As Australian shares brace for a challenging day with the ASX 200 futures indicating a significant drop, the market sentiment has been further unsettled by both domestic political shifts and international economic disruptions. In this clim…
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Sometimes these stories can cloud the minds of investors, leading them to invest wi…
As of October 2025, the Australian market has shown resilience with the S&P/ASX 200 index climbing past the 9,000-point mark despite mixed economic signals such as weak jobs data and stronger-than-expected inflation. In this dynamic enviro…
With its stock down 5.2% over the past three months, it is easy to disregard Pro Medicus (ASX:PME). But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in…
The Australian market has shown signs of nervousness, aligning with its Asian counterparts as investors anticipate the upcoming Federal Reserve rate cut decision, while profit-taking activities have tempered recent gains. In this climate o…
Visage receives ATO for the Veterans Affairs Enterprise Cloud (VAEC) SAN DIEGO, Sept. 4, 2025 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it has been granted an A…
The Australian market has recently experienced a mix of highs and lows, with the ASX200 showing a 1.5% increase over the past month despite some setbacks from major players like CSL, which contributed to a downturn on Tuesday. In this dyna…
Explore Pro Medicus's Fair Values from the Community and select yours Pro Medicus (ASX:PME) Full Year 2025 Results Key Financial Results Revenue: AU$213.0m (up 32% from FY 2024). Net income: AU$115.2m (up 39% from FY 2024). Profit margin:…
As we reach the end of the first day of Week 30 in 2025, the Australian market experienced a pullback with the ASX dipping back to the high 8,600s after an unexpected climb into the 8,700s on Friday. Despite this minor setback and profit-t…
Key Insights Pro Medicus' significant insider ownership suggests inherent interests in company's expansion 51% of the business is held by the top 4 shareholders 14% of Pro Medicus is held by Institutions We've found 21 US stocks that are f…
In the current Australian market landscape, the ASX 200 futures are indicating a slight dip of -0.2% amid geopolitical tensions and mixed economic signals, while unemployment remains stable at 4.1%. Against this backdrop, high growth tech…
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality companies can see their share prices grow by huge amounts. Just think about the savvy investors who held Pro Medicus Limited (AS…
The Australian market is experiencing a challenging phase, with the ASX 200 expected to open lower due to trade concerns from the U.S., while Wall Street's recent downturn has added further pressure, particularly impacting tech stocks. In…
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Sometimes these stories can cloud the minds of investors, leading them to invest…
The Australian market has been experiencing a period of volatility, with recent developments such as Trump's decision to ease tariffs on China contributing to the ASX's movement back towards the 8,000-point mark. In this dynamic environmen…